20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

THE LAWSUIT: A class action securities lawsuit was filed against Moderna, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 18, ...

Moderna's,(NASDAQ:MRNA),recent 13% drop in stock price following its announcement of significant cost cuts has raised ...

Health Canada has approved an updated Novavax COVID-19 vaccine to protect against the variants of the virus currently ...

Monash University researchers have developed a new technique to boost the effectiveness of both traditional and mRNA-based vaccines in animal ...

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...